JPH06142178A - Tape agent and tape preparation having decreased stimulus on skin - Google Patents
Tape agent and tape preparation having decreased stimulus on skinInfo
- Publication number
- JPH06142178A JPH06142178A JP4294432A JP29443292A JPH06142178A JP H06142178 A JPH06142178 A JP H06142178A JP 4294432 A JP4294432 A JP 4294432A JP 29443292 A JP29443292 A JP 29443292A JP H06142178 A JPH06142178 A JP H06142178A
- Authority
- JP
- Japan
- Prior art keywords
- tape
- skin
- adhesive layer
- support
- pore volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は皮膚面に貼付して使用す
るテープ剤および経皮吸収用薬物を含有するテープ製剤
に関し、詳しくは粘着剤層と支持体との投錨性が良好で
あり、しかも皮膚面に長時間貼付した場合に皮膚面に対
してムレやカブレなどの皮膚刺激がほとんど生じない皮
膚刺激性の少ないテープ剤およびテープ製剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a tape preparation to be used by being stuck on the skin surface and a tape preparation containing a drug for percutaneous absorption. More specifically, the anchoring property between the adhesive layer and the support is good, Moreover, the present invention relates to a tape preparation and a tape preparation having little skin irritation, which hardly causes skin irritation such as stuffiness or rash on the skin surface when applied to the skin surface for a long time.
【0002】[0002]
【従来の技術】皮膚面に貼付して使用するテープ剤とし
ては、皮膚面の保護などに用いる被覆用のテープ剤や、
経皮投与用の薬物を経皮的に体内へ投与するために用い
るテープ製剤など各種用途に使用されているが、貼付面
が皮膚面であるのでその開発に当たっては、貼付時の取
扱性や皮膚面の動きに対する追従性(柔軟性)に加え
て、皮膚に対する無刺激性などが要求される。特に、こ
れらのテープ剤は比較的長時間にわたって貼付する場合
があるので、皮膚面への貼付後の違和感や皮膚に対する
刺激性を発現しないものが重要な要求特性となる。2. Description of the Related Art As a tape agent to be applied to the skin surface, a tape agent for covering used for protecting the skin surface,
It is used in various applications such as tape preparations used to transdermally administer drugs for transdermal administration.However, since the patch surface is the skin surface, the development of the patch is easy to handle and skin. In addition to the ability to follow the movement of the surface (flexibility), non-irritancy to the skin is required. In particular, since these tapes may be applied for a relatively long time, it is an important required property that they do not give a feeling of discomfort or irritation to the skin after being applied to the skin surface.
【0003】このような要求に応じるものとしては、従
来から支持体の厚みをできるだけ薄くして支持体のエッ
ジ部による皮膚刺激性を低減し、さらに皮膚追従性を付
与したテープ剤が提案されている。しかしながら、支持
体の厚みを薄くした場合、上記要求特性は満足できるも
ののテープ剤自体に自己支持性がなくなるので貼付時の
取扱性が悪くなり、貼付後のテープ剤に皺を生じたり、
また貼付時に粘着面同士がくっついて綺麗に貼付できな
いという問題を有するようになる。In order to meet such demands, there has conventionally been proposed a tape preparation in which the thickness of the support is made as thin as possible to reduce the skin irritation caused by the edge portion of the support and further the skin followability is imparted. There is. However, when the thickness of the support is reduced, the above-mentioned required characteristics are satisfied, but the tape agent itself loses its self-supporting property, resulting in poor handleability at the time of application and wrinkling of the tape agent after application,
In addition, there is a problem in that the adhesive surfaces are stuck to each other at the time of application and cannot be applied neatly.
【0004】また、長時間皮膚面に貼付した場合、皮膚
面を被覆しているので貼付面が発汗などによってムレ
て、それによって痒みやカブレが生じ、時にはただれる
こともある。Further, when applied to the skin surface for a long time, since the skin surface is covered, sweating or the like causes the application surface to become stuffy, resulting in itching or rash and sometimes sickness.
【0005】そこで、上記問題を解決する方法として、
連続気泡体からなる多孔性シートや不織布や織布のよう
な布基材を支持体に用いて、適度な自己支持性を維持し
つつ通気性も付与したテープ剤やテープ製剤も種々提案
されている。Therefore, as a method for solving the above problem,
Various tapes and tape preparations have been proposed that use a porous sheet made of open cells or a cloth base material such as a non-woven fabric or a woven fabric as a support, while maintaining a proper self-supporting property while also providing air permeability. There is.
【0006】連続気泡体の多孔性シートを支持体に用い
た場合、通常、支持体表面の開口率のみが問題視されて
いるが、支持体の厚みが厚い場合には充分な通気性を得
ることができず、貼付皮膚面のムレなどを防止するため
には支持体の厚みによる影響も考慮する必要がある。ま
た、不織布のような布基材を支持体として用いた場合に
も、一定面積における布基材の重量、所謂目付量(坪
量)のみが論議されているが、上記と同様に厚みの要因
も大きく作用するものである。When a porous sheet of open cells is used as a support, only the aperture ratio on the surface of the support is usually regarded as a problem, but when the support has a large thickness, sufficient air permeability is obtained. However, it is necessary to consider the influence of the thickness of the support in order to prevent the sticking skin surface from getting stuffy. Also, when a cloth substrate such as a non-woven fabric is used as a support, only the weight of the cloth substrate in a certain area, that is, the so-called basis weight (basis weight) is only discussed. Also has a great effect.
【0007】[0007]
【発明が解決しようとする課題】そこで、本発明者らは
連続気泡体や布基材のような多孔性支持体において、支
持体の厚みとムレなどの皮膚刺激性との関係について検
討を重ねた結果、単なる開口率ではなく、厚みの要因も
考慮した気孔容積が皮膚刺激性と相関性を有することを
見い出し、本発明を完成するに至った。Therefore, the present inventors have repeatedly studied the relationship between the thickness of the support and the skin irritation such as stuffiness in a porous support such as an open-cell body or a cloth substrate. As a result, they have found that the pore volume in consideration of the thickness factor, not just the aperture ratio, has a correlation with the skin irritation, and have completed the present invention.
【0008】[0008]
【課題を解決するための手段】即ち、本発明はJISL
−1096に規定する気孔容積が40〜98%である多
孔性支持体の少なくとも片面に粘着剤層を積層してなる
皮膚刺激性の少ないテープ剤を提供するものであり、自
己支持性と皮膚刺激性のバランスの面からは該多孔性支
持体の剛軟度(JISL−1096に規定する45度カ
ンチレバー法による)を100mm以下としたテープ剤
が好ましい。SUMMARY OF THE INVENTION That is, the present invention is based on JISL.
The present invention provides a tape preparation having a low skin irritation, which is obtained by laminating an adhesive layer on at least one surface of a porous support having a pore volume of 40 to 98% specified in 1096. From the viewpoint of the balance of properties, a tape preparation in which the bending resistance of the porous support (according to the 45-degree cantilever method specified in JIS L-1096) is 100 mm or less is preferable.
【0009】さらに、本発明は上記テープ剤における粘
着剤層中に経皮吸収用薬物を含有してなるテープ製剤も
提供するものである。Further, the present invention also provides a tape preparation containing a drug for percutaneous absorption in the adhesive layer of the above tape preparation.
【0010】本発明のテープ剤は粘着剤層を少なくとも
片面に積層支持する支持体に特徴を有するものであり、
その気孔容積が40〜98%、好ましくは50〜95%
の値を有するものを用いる。本発明における「気孔容
積」とは、JISL−1096に規定する気孔容積を云
い、下記式によって算出される値であって、所謂気孔率
や開口率とは異なるものである。The tape agent of the present invention is characterized by a support for laminating and supporting an adhesive layer on at least one side,
Its pore volume is 40-98%, preferably 50-95%
The one having the value of is used. The "pore volume" in the present invention refers to the pore volume specified in JIS L-1096, and is a value calculated by the following formula, which is different from the so-called porosity and opening rate.
【0011】[0011]
【数1】 [Equation 1]
【0012】本発明のテープ剤においては上記気孔容積
に調整し、さらに皮膚刺激性の軽減のために多孔性支持
体の通気度(JISL−1096に規定するA法によ
る)を3〜500cm3 /cm2 /sec、好ましくは
5〜400cm3 /cm2 /sec、さらには50〜3
00cm3 /cm2 /secとなるように調整すること
が好ましい。In the tape preparation of the present invention, the pore volume is adjusted to the above-mentioned range, and in order to reduce skin irritation, the air permeability (according to the A method defined in JIS L-1096) of the porous support is 3 to 500 cm 3 / cm 2 / sec, preferably 5 to 400 cm 3 / cm 2 / sec, further 50 to 3
It is preferable to adjust it to be 00 cm 3 / cm 2 / sec.
【0013】多孔性支持体の気孔容積が40%に満たな
い場合には、皮膚刺激性の低減効果が充分でなく、また
98%を超える気孔容積であると、支持体背面からの粘
着剤の滲出や支持体の機械的強度が不足することがあ
る。また、経皮吸収用薬物を含有させてテープ製剤とし
た場合に、支持体背面からの薬物が裏抜けして含量低下
を起こすこともあり、好ましくない。When the pore volume of the porous support is less than 40%, the effect of reducing skin irritation is not sufficient, and when the pore volume exceeds 98%, the pressure-sensitive adhesive from the back surface of the support is Exudation and mechanical strength of the support may be insufficient. Further, when a drug for transdermal absorption is contained in a tape preparation, the drug from the back surface of the support may strike through to cause a decrease in content, which is not preferable.
【0014】また、上記多孔性支持体はあまり剛性が大
きいと支持体のエッジ部に接触する皮膚面に物理的刺激
を与えるので好ましくなく、JISL−1096に規定
する45度カンチレバー法による剛軟度で100mm以
下、好ましくは20〜90mm程度の値とすることが望
ましい。Further, if the above-mentioned porous support is too rigid, it gives physical irritation to the skin surface in contact with the edge of the support, which is not preferable, and the flexibility of the 45 ° cantilever method defined in JIS L-1096 is not preferable. It is desirable that the value is 100 mm or less, preferably about 20 to 90 mm.
【0015】このような多孔性支持体としては、上記特
性を満足するものであれば、その材質には制限はなく、
例えばポリエステル、ナイロン(ポリアミド)、サラ
ン、ポリエチレン、ポリプロピレン、ポリ塩化ビニル、
ポリテトラフルオロエチレン、ポリウレタン、レーヨ
ン、アクリル、ビニロン、アセテート、トリアセテート
などからなるものが採用される。本発明の多孔性支持体
はこのような材質からなるフィルムもしくはシートに穿
孔処理を施したり、任意の発泡剤を加えてフィルム化も
しくはシート化して連続気泡化したり、さらにはシート
用のポリマーと、これに相溶しない液状成分とを混合し
てシート状に成形したのち、延伸したり溶媒抽出するこ
とによって得ることができる。また、シート用のポリマ
ー粉末を完全に溶融、融着しない温度でシート状に成形
することによって多孔化することもできる。また、上記
材質の繊維から織布、不織布、編布などの布基材に加工
することによって作製することもできる。As such a porous support, the material is not limited as long as it satisfies the above-mentioned characteristics.
For example, polyester, nylon (polyamide), saran, polyethylene, polypropylene, polyvinyl chloride,
Those made of polytetrafluoroethylene, polyurethane, rayon, acrylic, vinylon, acetate, triacetate, etc. are adopted. The porous support of the present invention is a film or sheet made of such a material is subjected to a perforating treatment, or an optional foaming agent is added to form a film or sheet to form open cells, and further a polymer for a sheet, It can be obtained by mixing with a liquid component which is incompatible with this and forming it into a sheet, and then stretching or solvent extraction. Alternatively, the polymer powder for a sheet can be made porous by molding it into a sheet at a temperature at which it is not completely melted or fused. It can also be produced by processing fibers of the above materials into a cloth base material such as woven cloth, non-woven cloth, and knitted cloth.
【0016】本発明のテープ剤は上記した多孔性支持体
の少なくとも片面に粘着剤層を形成してなるものであ
る。形成する粘着剤層としては、皮膚面に接触すること
から粘着剤自体に皮膚刺激性を有しない医療用途の粘着
剤であれば、(メタ)アクリル酸アルキルエステルを主
成分とするアクリル系粘着剤、ポリイソブチレンやポリ
イソプレン、ポリブタジエン、スチレン/イソプレン
(もしくはブタジエン)/スチレンブロック共重合体な
どからなるゴム系粘着剤、ビニルアルキルエーテルを主
成分とするビニルエーテル系粘着剤、ポリオルガノシロ
キサンを主成分とするシリコーン系粘着剤などを問わず
用いることができる。これらの粘着剤のうち品質の安定
性や粘着力の調整の容易さ、薬物の放出性などの点か
ら、(メタ)アクリル酸アルキルエステルを50重量%
以上重合して得られるアクリル系粘着剤を好ましく用い
ることができる。また、皮膚面に貼付した際にソフト感
を与えてさらに刺激性を低減するために上記粘着剤成分
と相溶するアルキレングリコールや油脂類、液状界面活
性剤、可塑剤、脂肪酸エステル類、有機溶剤などの有機
液状成分を20〜70重量%、好ましくは40〜60重
量%程度含有させ、さらに凝集力を向上させるために必
要に応じて架橋処理を施した粘着剤を用いることが好ま
しい。The tape preparation of the present invention comprises an adhesive layer formed on at least one surface of the above-mentioned porous support. As the pressure-sensitive adhesive layer to be formed, an acrylic pressure-sensitive adhesive containing (meth) acrylic acid alkyl ester as a main component, as long as it is a pressure-sensitive adhesive for medical use that does not cause skin irritation to the pressure-sensitive adhesive itself because it contacts the skin surface. Rubber adhesives made of polyisobutylene, polyisoprene, polybutadiene, styrene / isoprene (or butadiene) / styrene block copolymers, vinyl ether adhesives containing vinyl alkyl ether as the main component, and polyorganosiloxane as the main component Any silicone-based pressure-sensitive adhesive or the like can be used. Of these adhesives, 50% by weight of (meth) acrylic acid alkyl ester is used from the viewpoints of quality stability, easy adjustment of adhesive strength, drug release, etc.
The acrylic pressure-sensitive adhesive obtained by the above polymerization can be preferably used. In addition, alkylene glycol and oils and fats, liquid surfactants, plasticizers, fatty acid esters, organic solvents that are compatible with the above-mentioned pressure-sensitive adhesive component to give a soft feeling when attached to the skin surface and further reduce irritation It is preferable to use an adhesive containing 20 to 70% by weight, preferably 40 to 60% by weight of an organic liquid component such as, and optionally subjected to crosslinking treatment to improve cohesive strength.
【0017】本発明における上記粘着剤層は皮膚面に直
接接触、被覆する層であるので、貼付中に過度のムレな
どを起こさないようにすることが皮膚に対する刺激の軽
減のためには好ましい。このような点からは粘着剤層の
透湿度(JISZ−0208に規定するカップ法で40
℃、90%RHによる)を200g/m2 ・24h以上
に調整することがより好ましいものである。Since the pressure-sensitive adhesive layer in the present invention is a layer that directly contacts and covers the skin surface, it is preferable to prevent excessive stuffiness during application in order to reduce irritation to the skin. From such a point, the moisture permeability of the adhesive layer (40% by the cup method specified in JIS Z-0208)
It is more preferable to adjust the temperature (at 90 ° C. and 90% RH) to 200 g / m 2 · 24 h or more.
【0018】また、本発明における粘着剤層には経皮吸
収用の薬物を含有させて各種疾患の治療または予防を行
う経皮吸収用のテープ製剤とすることができる。このよ
うな薬物としては経皮吸収されて薬理効果を発揮するも
のであれば、局所性薬物や全身性薬物のいずれを用いて
もよく、具体的にはコルチコステロイド類、鎮痛消炎
剤、催眠鎮静剤、精神安定剤、抗高血圧剤、降圧利尿
剤、抗生物質、麻酔剤、抗真菌剤、ビタミン剤、冠血管
拡張剤、抗ヒスタミン剤、鎮咳剤、性ホルモン、抗鬱
剤、脳循環改善剤、制吐剤、抗腫瘍剤、生体医薬などの
薬物が使用できる。なお、これらの薬物は必要により2
種類以上を併用して含有させることができる。また、上
記粘着剤中での経皮吸収用薬物の溶解性や拡散移動によ
る放出性を良好にするためには、用いる薬物は常温下で
水100mlに対して0.4g以下の溶解量である脂溶
性の薬物を用いることが好ましい。Further, the adhesive layer in the present invention may contain a drug for percutaneous absorption to prepare a percutaneous absorption tape preparation for treating or preventing various diseases. As such a drug, any of a local drug and a systemic drug may be used as long as it exerts a pharmacological effect by being transdermally absorbed, and specifically, corticosteroids, analgesic and anti-inflammatory agents, hypnotics. Sedatives, tranquilizers, antihypertensives, antihypertensives, antibiotics, anesthetics, antifungals, vitamins, coronary vasodilators, antihistamines, antitussives, sex hormones, antidepressants, cerebral circulation improvers, antiemetics , Drugs such as antitumor agents and biomedical agents can be used. If necessary, these drugs may
More than one kind can be contained in combination. Further, in order to improve the solubility of the drug for transdermal absorption in the adhesive and the release due to diffusion transfer, the amount of the drug used is 0.4 g or less in 100 ml of water at room temperature. It is preferable to use a fat-soluble drug.
【0019】これらの経皮吸収用薬物の含有量は薬物種
や投与目的に応じて適宜設定することができるが、通
常、粘着剤層中に1〜40重量%、好ましくは2〜30
重量%程度含有させる。含有量が1重量%に満たない場
合は治療に有効な量の薬物放出が期待できず、また、4
0重量%を超えるとそれ以上の治療効果が期待できず経
済的に不利となる。The content of these drugs for percutaneous absorption can be appropriately set according to the drug species and the purpose of administration, but it is usually 1 to 40% by weight, preferably 2 to 30% in the pressure-sensitive adhesive layer.
Approximately wt% is included. If the content is less than 1% by weight, a therapeutically effective amount of drug cannot be expected to be released.
If it exceeds 0% by weight, no further therapeutic effect can be expected, which is economically disadvantageous.
【0020】[0020]
【発明の効果】以上のように本発明のテープ剤は特定の
気孔容積を有する多孔性支持体を用いたテープ剤である
ので、貼付操作時に適度な自己支持性を有し取扱性に優
れていると共に、貼付後のムレなどによる皮膚刺激性を
顕著に改善できるという効果を発揮する。さらに、粘着
剤層中に経皮吸収用薬物を含有させたテープ製剤におい
ては、薬物が適度な密封包帯療法(ODT)によって期
待すべき薬理効果を発揮できるものである。As described above, since the tape preparation of the present invention is a tape preparation using a porous support having a specific pore volume, it has a proper self-supporting property at the time of application and has excellent handleability. It also has the effect of significantly improving skin irritation caused by stuffiness after application. Furthermore, in a tape preparation containing a drug for transdermal absorption in an adhesive layer, the drug can exert an expected pharmacological effect by an appropriate occlusive dressing therapy (ODT).
【0021】[0021]
【実施例】以下に本発明の実施例を示し、さらに具体的
に説明する。なお、以下において、部および%は重量部
および重量%を意味する。EXAMPLES Examples of the present invention will be shown below and will be described more specifically. In the following, parts and% mean parts by weight and% by weight.
【0022】実施例1 不活性ガス雰囲気下でアクリル酸2−エチルヘキシルエ
ステル95部とアクリル酸5部とを酢酸エチル中で共重
合させて、アクリル系粘着剤溶液を調製した。Example 1 95 parts of acrylic acid 2-ethylhexyl ester and 5 parts of acrylic acid were copolymerized in ethyl acetate under an inert gas atmosphere to prepare an acrylic pressure-sensitive adhesive solution.
【0023】このようにして得た粘着剤溶液をポリエス
テル製のセパレータ上に乾燥後の厚みが40μmとなる
ように塗布乾燥して粘着剤層(透湿度590g/m2 ・
24h)を作製し、この粘着剤層を支持体としての多孔
性レーヨン不織布(気孔容積92%、通気度208cm
3 /cm2 /sec、剛軟度35mm)に転写、積層し
て本発明のテープ剤を作製した。The pressure-sensitive adhesive solution thus obtained was coated and dried on a polyester separator so that the thickness after drying was 40 μm, and the pressure-sensitive adhesive layer (moisture permeability 590 g / m 2 ·.
24h) was prepared, and this adhesive layer was used as a support for a porous rayon nonwoven fabric (pore volume: 92%, air permeability: 208 cm).
The tape agent of the present invention was produced by transferring and laminating at 3 / cm 2 / sec and a bending resistance of 35 mm).
【0024】実施例2 実施例1における支持体を多孔性ポリエステル不織布
(気孔容積72%、通気度204cm3 /cm2 /se
c、剛軟度48mm)に代えた以外は、実施例1と同様
にして本発明のテープ剤を作製した。Example 2 The support used in Example 1 was a porous polyester nonwoven fabric (pore volume 72%, air permeability 204 cm 3 / cm 2 / se).
c, bending resistance 48 mm), except that the tape agent of the present invention was produced in the same manner as in Example 1.
【0025】実施例3 実施例1にて調製したアクリル系粘着剤溶液の固形分5
0部に、ミリスチン酸イソプロピル50部を混合し、さ
らにアクリル系粘着剤の固形分99.8部に対して0.
2部のエチルアセトアセテートアルミニウムジイソプロ
ピレートを10%アセチルアセトン溶液として添加し、
これをポリエステル製のセパレータ上に乾燥後の厚みが
60μmとなるように塗布乾燥して架橋したゲル状の粘
着剤層(透湿度500g/m2 ・24h)を作製し、こ
の粘着剤層を支持体としての多孔性レーヨン不織布(気
孔容積92%、通気度208cm3 /cm2 /sec、
剛軟度35mm)に転写、積層して本発明のテープ剤を
作製した。Example 3 Solid content 5 of the acrylic pressure-sensitive adhesive solution prepared in Example 1
50 parts of isopropyl myristate was mixed with 0 part of the mixture, and the amount was adjusted to 0.
Add 2 parts ethyl acetoacetate aluminum diisopropylate as a 10% acetylacetone solution,
This was applied on a polyester separator so that the thickness after drying was 60 μm, and dried to form a crosslinked gel-like pressure-sensitive adhesive layer (water vapor transmission rate 500 g / m 2 · 24 h), and this pressure-sensitive adhesive layer was supported. Porous rayon nonwoven fabric as a body (pore volume 92%, air permeability 208 cm 3 / cm 2 / sec,
The tape agent of the present invention was produced by transferring and laminating to a bending resistance of 35 mm).
【0026】実施例4 実施例3における支持体を多孔性ポリエステル不織布
(気孔容積72%、通気度204cm3 /cm2 /se
c、剛軟度48mm)に代えた以外は、実施例1と同様
にして本発明のテープ剤を作製した。Example 4 The support used in Example 3 was a porous polyester nonwoven fabric (pore volume 72%, air permeability 204 cm 3 / cm 2 / se).
c, bending resistance 48 mm), except that the tape agent of the present invention was produced in the same manner as in Example 1.
【0027】実施例5 実施例1における支持体を多孔性ポリテトラフルオロエ
チレンシート(気孔容積54%、通気度6.5cm3 /
cm2 /sec、剛軟度40mm)に代えた以外は、実
施例1と同様にして本発明のテープ剤を作製した。Example 5 The support in Example 1 was replaced with a porous polytetrafluoroethylene sheet (pore volume 54%, air permeability 6.5 cm 3 /
The tape agent of the present invention was produced in the same manner as in Example 1 except that the hardness was changed to cm 2 / sec and the bending resistance of 40 mm).
【0028】比較例1 実施例1における支持体を多孔性ポリウレタンシート
(気孔容積38%、通気度76cm3 /cm2 /se
c、剛軟度28mm)に代えた以外は、実施例1と同様
にしてテープ剤を作製した。Comparative Example 1 A porous polyurethane sheet (pore volume 38%, air permeability 76 cm 3 / cm 2 / se was used as the support in Example 1).
c, bending resistance 28 mm), except that the tape was prepared in the same manner as in Example 1.
【0029】比較例2 実施例1における支持体を多孔性ポリエステルシート
(気孔容積38%、通気度40cm3 /cm2 /se
c、剛軟度30mm)に代えた以外は、実施例1と同様
にしてテープ剤を作製した。Comparative Example 2 The support used in Example 1 was replaced with a porous polyester sheet (pore volume 38%, air permeability 40 cm 3 / cm 2 / se).
c, bending resistance 30 mm), except that the tape agent was prepared in the same manner as in Example 1.
【0030】比較例3 実施例3における支持体を多孔性ポリウレタンシート
(気孔容積38%、通気度76cm3 /cm2 /se
c、剛軟度28mm)に代えた以外は、実施例3と同様
にしてテープ剤を作製した。Comparative Example 3 The support used in Example 3 was replaced with a porous polyurethane sheet (pore volume 38%, air permeability 76 cm 3 / cm 2 / se).
c, bending resistance 28 mm) except that the tape agent was prepared in the same manner as in Example 3.
【0031】実施例6 実施例1における支持体を多孔性ポリエステル不織布
(気孔容積76%、通気度198cm3 /cm2 /se
c、剛軟度115mm)に代えた以外は、実施例1と同
様にしてテープ剤を作製した。Example 6 The support used in Example 1 was a porous polyester non-woven fabric (pore volume 76%, air permeability 198 cm 3 / cm 2 / se).
c, the bending resistance was 115 mm), and a tape preparation was prepared in the same manner as in Example 1.
【0032】実施例7 スチレン/イソプレン/スチレンブロック共重合体10
0部と、ポリブテン15部と、粘着付与樹脂(商品名ア
ルコンP−100、荒川工業社製)85部とを、トルエ
ンに溶解してゴム系粘着剤溶液を調製した。Example 7 Styrene / isoprene / styrene block copolymer 10
A rubber-based pressure-sensitive adhesive solution was prepared by dissolving 0 part, 15 parts of polybutene, and 85 parts of a tackifying resin (trade name Alcon P-100, manufactured by Arakawa Industry Co., Ltd.) in toluene.
【0033】このようにして得た粘着剤溶液をポリエス
テル製のセパレータ上に乾燥後の厚みが40μmとなる
ように塗布乾燥して粘着剤層(透湿度172g/m2 ・
24h)を作製し、この粘着剤層を支持体としての多孔
製レーヨン不織布(気孔容積92%、通気度208cm
3 /cm2 /sec、剛軟度35mm)に転写、積層し
て本発明のテープ剤を作製した。The pressure-sensitive adhesive solution thus obtained was coated and dried on a polyester separator so that the thickness after drying was 40 μm, and the pressure-sensitive adhesive layer (moisture permeability 172 g / m 2 ·.
24h) was prepared, and a porous rayon nonwoven fabric (pore volume 92%, air permeability 208 cm) using this adhesive layer as a support was prepared.
The tape agent of the present invention was produced by transferring and laminating at 3 / cm 2 / sec and a bending resistance of 35 mm).
【0034】実施例8 実施例1における粘着剤層中に粘着剤の固形分80部に
対して、イソソルビドジニトレート20部を加えて経皮
吸収用薬物含有の粘着剤層とした以外は、実施例1と同
様にして本発明のテープ製剤を作製した。Example 8 Example 8 was repeated except that 20 parts of isosorbide dinitrate was added to 80 parts of the solid content of the pressure-sensitive adhesive in the pressure-sensitive adhesive layer to form a drug-containing pressure-sensitive adhesive layer for transdermal absorption. A tape preparation of the present invention was prepared in the same manner as in Example 1.
【0035】比較例4 実施例8における支持体を多孔性ポリウレタンシート
(気孔容積38%、通気度76cm3 /cm2 /se
c、剛軟度28mm)に代えた以外は、実施例8と同様
にしてテープ製剤を作製した。Comparative Example 4 The support in Example 8 was replaced with a porous polyurethane sheet (pore volume 38%, air permeability 76 cm 3 / cm 2 / se).
c, bending resistance 28 mm) except that the tape preparation was prepared in the same manner as in Example 8.
【0036】比較例5 実施例1における支持体を12μm厚のポリエステルシ
ート(気孔容積0%、通気度1.9×10-7cm3 /c
m2 /sec、剛軟度30mm)に代えた以外は、実施
例1と同様にしてテープ剤を作製した。Comparative Example 5 A polyester sheet having a thickness of 12 μm (pore volume 0%, air permeability 1.9 × 10 −7 cm 3 / c) was used as the support in Example 1.
A tape preparation was produced in the same manner as in Example 1 except that m 2 / sec and bending resistance of 30 mm) were used.
【0037】上記各実施例および各比較例にて得たテー
プ剤およびテープ製剤を用いて下記試験を行った。その
結果を表1に示す。The following tests were carried out using the tape preparations and tape preparations obtained in the above Examples and Comparative Examples. The results are shown in Table 1.
【0038】〔貼付感〕25cm2 の大きさに裁断した
各サンプルをボランティア6名の胸部に6時間貼付し、
その際の貼付感を下記の基準によって評価し、その平均
値を求めた。 3:違和感がなく良好である。[Peeling feeling] Each sample cut into a size of 25 cm 2 was stuck on the chest of 6 volunteers for 6 hours,
The sticking feeling at that time was evaluated according to the following criteria, and the average value was obtained. 3: Good with no discomfort.
【0039】2:やや違和感がある。 1:かなり違和感がある。2: There is some discomfort. 1: There is a feeling of strangeness.
【0040】〔皮膚刺激性〕上記貼付感試験における各
サンプルを24時間貼付後、皮膚面から剥離除去し、剥
離後30分、4時間、24時間、48時間経過後の皮膚
面を観察した。皮膚刺激の程度は本邦パッチテスト基準
に基づいて判定し、その評点の平均値を求めた。[Skin Irritation] Each sample in the above patch feeling test was stuck for 24 hours, peeled off from the skin surface, and the skin surface was observed after 30 minutes, 4 hours, 24 hours, and 48 hours after peeling. The degree of skin irritation was judged based on the Japanese patch test standard, and the average of the scores was calculated.
【0041】(−) 反応なし 評点0.0点 (±) 軽い紅斑 評点0.5点 (+) 紅斑 評点1.0点 (++)紅斑と浮腫 評点2.0点(-) No reaction, score: 0.0 (±) Light erythema, score: 0.5 (+) Erythema, score of 1.0 (++) Erythema and edema, score: 2.0
【0042】[0042]
【表1】 [Table 1]
───────────────────────────────────────────────────── フロントページの続き (72)発明者 木之下 隆士 大阪府茨木市下穂積1丁目1番2号 日東 電工株式会社内 ─────────────────────────────────────────────────── --- Continuation of the front page (72) Inventor Takashi Kinoshita 1-2-1, Shimohozumi, Ibaraki City, Osaka Prefecture Nitto Denko Corporation
Claims (3)
が40〜98%である多孔性支持体の少なくとも片面に
粘着剤層を積層してなる皮膚刺激性の少ないテープ剤。1. A tape preparation having a low skin irritation, which is obtained by laminating an adhesive layer on at least one surface of a porous support having a pore volume of 40 to 98% specified in JIS L-1096.
96に規定する45度カンチレバー法による)が100
mm以下である請求項1記載のテープ剤。2. The bending resistance (JISL-10) of the porous support.
100 according to the 45-degree cantilever method specified in 96)
The tape preparation according to claim 1, which has a size of not more than mm.
剤層中に経皮吸収用薬物を含有してなるテープ製剤。3. The tape preparation according to claim 1, wherein the adhesive layer contains a drug for percutaneous absorption.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4294432A JPH06142178A (en) | 1992-11-02 | 1992-11-02 | Tape agent and tape preparation having decreased stimulus on skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4294432A JPH06142178A (en) | 1992-11-02 | 1992-11-02 | Tape agent and tape preparation having decreased stimulus on skin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06142178A true JPH06142178A (en) | 1994-05-24 |
Family
ID=17807694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4294432A Pending JPH06142178A (en) | 1992-11-02 | 1992-11-02 | Tape agent and tape preparation having decreased stimulus on skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06142178A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09154933A (en) * | 1995-12-12 | 1997-06-17 | Nitto Denko Corp | Medical adhesive tape and first-acid adhesive tape |
JPH10101553A (en) * | 1996-09-24 | 1998-04-21 | Bando Chem Ind Ltd | Substrate for percutaneously administrative medicine |
WO2005051333A1 (en) * | 2003-11-28 | 2005-06-09 | Coloplast A/S | An adhesive patch |
-
1992
- 1992-11-02 JP JP4294432A patent/JPH06142178A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09154933A (en) * | 1995-12-12 | 1997-06-17 | Nitto Denko Corp | Medical adhesive tape and first-acid adhesive tape |
JPH10101553A (en) * | 1996-09-24 | 1998-04-21 | Bando Chem Ind Ltd | Substrate for percutaneously administrative medicine |
WO2005051333A1 (en) * | 2003-11-28 | 2005-06-09 | Coloplast A/S | An adhesive patch |
EP2332585A1 (en) * | 2003-11-28 | 2011-06-15 | Coloplast A/S | An adhesive patch |
EP2332586A1 (en) * | 2003-11-28 | 2011-06-15 | Coloplast A/S | An adhesive patch |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7063859B1 (en) | Barrier film lined backing layer composition and method for topical administration of active agents | |
US5662925A (en) | Transdermal delivery system with adhesive overlay and peel seal disc | |
CA2692884C (en) | Dermal delivery device with in situ seal | |
US6149935A (en) | Solid matrix system for transdermal drug delivery | |
EP0743842B1 (en) | Drug-containing adhesive composite transdermal delivery device | |
US20180228739A1 (en) | Dermal Delivery Device | |
CA2065311C (en) | Solid matrix system for transdermal drug delivery | |
JP2700835B2 (en) | Acrylic gel material and acrylic gel preparation | |
US20040028726A1 (en) | Transdermal systems for the delivery of clonidine | |
JPS63233916A (en) | Elastic transdermal drug supply device, composition of fatty acid ester/ether of alkanediol as transdermally absorption promoter and device | |
WO1989007429A1 (en) | Printed transdermal drug delivery device | |
KR101809744B1 (en) | Water resistant patch preparation | |
JPH05309128A (en) | Adhesive plaster and adhesive plaster formulation | |
KR0163597B1 (en) | A percutaneous-administration type pharmaceutical preparation of nitroglycerin | |
JP3014188B2 (en) | Acrylic gel material and acrylic gel preparation | |
JPH09124462A (en) | Transdermal patch material and transdermal patch preparation | |
WO1998051288A1 (en) | Patch preparations for percutaneous absorption | |
JPH06142178A (en) | Tape agent and tape preparation having decreased stimulus on skin | |
JP2971998B2 (en) | Acrylic pressure-sensitive adhesive sheet and pressure-sensitive adhesive preparation using the same | |
JP3171935B2 (en) | Patch with excellent sticking properties | |
JP3184474B2 (en) | Transdermal formulation | |
JP2781016B2 (en) | Transdermal formulation | |
JPH0495023A (en) | Sustained release plaster | |
JPH0565224A (en) | Gelatinous material and therapeutic gel pharmaceutical using the same | |
EP0191783A1 (en) | Bandage for sustained delivery of drugs |